General | Seropositive | Seronegative | Number of participants (n = 85) | ||
---|---|---|---|---|---|
Gender | Male | 27 (38.03 %) | 44 (61.97 %) | 71 | |
Female | 4 (28.57 %) | 10 (71.43 %) | 14 | ||
TBEV | 20–35 | 9 (23.08 %) | 30 (76.92 %) | 39 | |
Age (years) | 36–50 | 7 (30.43 %) | 16 (69.57 %) | 23 | |
51–60 | 15 (65.22 %) | 8 (34.78 %) | 23 | ||
CCHFV | 0 (0 %) | 85 (100 %) | 85 |